ToolGen (XKRX:199800) ROCE % : 132.84% (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is ToolGen ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ToolGen's annualized ROCE % for the quarter that ended in Dec. 2024 was 132.84%.

ToolGen ROCE % Historical Data

The historical data trend for ToolGen's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ToolGen ROCE % Chart

ToolGen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-50.06

-35.31

-23.08

-51.35

11.63

ToolGen Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-160.79	-19.16	-25.66	-21.84	132.84

ToolGen ROCE % Calculation

ToolGen's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	8813.423	/	( ( (93450.754 - 1771.12)	+	(75478.506 - 15640.248) )	/ 2 )
	=	8813.423	/	( (91679.634	+	59838.258)	/ 2 )
	=	8813.423	/	75758.946
	=	11.63 %

ToolGen's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	91999.616	/	( ( (81775.079 - 3105.078)	+	(75478.506 - 15640.248) )	/ 2 )
	=	91999.616	/	( ( 78670.001	+	59838.258 )	/ 2 )
	=	91999.616	/	69254.1295
	=	132.84 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

ToolGen (XKRX:199800) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ToolGen ROCE % Related Terms

Thank you for viewing the detailed overview of ToolGen's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

ToolGen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

KOR-collar Gasan Digital Valley 1 to 219 digital Byeoksan, 6th 1204 No. ENG No. 1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, KOR

Website

http://www.toolgen.com

ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.

ToolGen Headlines

No Headlines